Rigel Pharmaceuticals GAAP EPS of $13.54 beats by $12.31, revenue of $69.8M beats by $1.1M
Source: SeekingAlpha
2026-03-03 16:05:02 ET
More on Rigel Pharmaceuticals
- Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026
- Rigel Pharmaceuticals, Inc. (RIGL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Rigel Pharma: Formulating A Game Plan For 2026
- Rigel Pharmaceuticals Q4 2025 Earnings Preview
- Top Quant rated bullish small cap stocks among companies with high short interest
Read the full article on Seeking Alpha
For further details see:
Rigel Pharmaceuticals GAAP EPS of $13.54 beats by $12.31, revenue of $69.8M beats by $1.1M
Rigel Pharmaceuticals Inc.
NASDAQ: RIGL
RIGL Trading
3.58% G/L:
$27.015 Last:
99,268 Volume:
$26.52 Open:
RIGL Latest News
March 03, 2026 04:01:00 pm
Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
RIGL Stock Data
$625,132,287
16,430,597
0.07%
54
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
